Safety, tolerability, pharmacokinetics and pharmacodynamics of multiple ascending doses of the novel long-acting glucagon analogue HM15136 in overweight and obese patients with co-morbidities.
Wonjung ShinMarcus HompeschJinHee ByeonSeohyun KangJaehyuk ChoiSeungJae BaekPublished in: Diabetes, obesity & metabolism (2023)
This study of HM15136 provides a preliminary safety and tolerability profile with initial insights into its efficacy profile.